From Investing.com:

AstraZeneca reports no supply issues due to Red Sea disruptions, says top executive Ruud Dobber. Attacks by Houthi militants in Yemen have led to global shipping disruptions, raising fears of inflation. The company is focusing on China, shunning India due to low prices. Reports of plans to spin off its Chinese business surface.



Read more: AstraZeneca says no supply snags so far from Red Sea disruptions By Reuters